HillSignal

TICKER INTELLIGENCE

Novavax, Inc. ($NVAX)

$9.35▼ 0.1% (7d)

NYSE/NASDAQ: NVAX

Washington Intelligence

1

Active Bills

0

Gov't Contracts

0

Congressional Trades

$NVAX is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $NVAX, including 1 bill. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.

Related Sectors

Healthcare

Congressional Legislation Affecting Novavax, Inc. ($NVAX)

End the Vaccine Carveout Act

BEARISH

S.3853 (End the Vaccine Carveout Act) is an early-stage bill with zero immediate market impact. It would repeal the liability shield for vaccine manufacturers, structurally disadvantaging pure-play vaccine companies like Moderna ($MRNA) and Novavax ($NVAX) that lack diversified revenue. The bill is in committee with one cosponsor — negligible passage probability.

→ Novavax's only approved product (NVX-CoV2373 COVID-19 vaccine) faces same liability exposure as Moderna, with no diversified revenue stream to absorb litigation costs.

S3853

Understanding These Signals

What is a Signal?Market SentimentFederal ContractsFull Glossary →

Get Full Access to Novavax, Inc. ($NVAX) Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Get Started →